Disclosure of Clinical Study Data
Sunovion Pharmaceuticals Inc believes that it should appropriately disclose to appropriate parties, including qualified researchers, information about and results of the clinical studies the Company sponsors. Our aim is to provide greater transparency, realizing the value clinical study data has in the best interests of patients, clinicians and medical research, contribution to scientific advancement, advancement of innovation, and enhancement of public health. In this regard, Sunovion adheres to requirements for the registration of our clinical studies and appropriately discloses study results in compliance with relevant laws, regulatory requirements, and industry guidelines for each country.
Sunovion provides access to our clinical study data through vivli.org effective 15Dec2022. The data provided are anonymized to protect personal information in accordance with relevant laws and regulations. Through defined processes using this site, qualified researchers may request relevant clinical study data. Sunovion has the right to refuse a data request if the requester has a potential conflict of interest or there is an actual or potential competitive risk identified.
Registration of Clinical Study Information and Summaries of Study Results
Sunovion registers and discloses information about and results of clinical studies that it sponsors on the following publicly available clinical trial registries:
|United States||Registration/Results||US National Library of Medicine Clinical Trials Database www.clinicaltrials.gov|
|Europe||Registration/Results||EU Clinical Trials Register (EU database) www.clinicaltrialsregister.eu|
Publication of Clinical Study Data
Sunovion seeks to have clinical study data on its sponsored studies presented at scientific meetings and published in peer-reviewed scientific and medical journals, regardless of the type of study or results.